Conversely, we observed a significant decrease in the percentage of tumor infiltrating Foxp3+ Treg cells among CD4+ population in anti-4-1BB/anti-CD73-treated mice, compared with anti-4-1BB-treated mice alone (Fig. 2e). The gene discussed is FOXP3; the disease is neoplasm.